TrialOpen forum infectious diseases2024

Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE Study.

Andrew Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.